Super-TDU treatment of adenomatous polyposis coli (APC) mutant mice (APCmin/+) (a mouse model typically used for colorectal and intestinal cancer) also significantly reduces the number and size of spontaneous adenomas without exhibiting detectable toxicity [161]. The gene discussed is APC; the disease is intestinal cancer.